Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Polyus invests ₽30 billion in the expansion of the Kuranakh mill

9/12/23 PLZL

Novatek to maintain gas production and increase liquids production in 2023

9/12/23 NVTK

Novatek expects year-on-year profit growth of 25% by 2021

9/12/23 NVTK

SPX Exchange fully switched to friendly accounting of Hong Kong securities

9/12/23 SPBE

Shareholders of INARCTICA approved dividends for 6 months 2023

9/12/23 AQUA

Seligdar invests ₽38 billion in projects in the Far East

9/12/23 SELG

Magnet opened a cheese shop in a superstore

9/12/23 MGNT

Astra Group of Companies to IPO in the fourth quarter

9/12/23 ASTR

Oracle reported for 3 months of fiscal year 2024

9/12/23 ORCL

Magnit bought back another 2,300 shares

9/12/23 MGNT